Cargando…

Pioglitazone Effect on Glioma Stem Cell Lines: Really a Promising Drug Therapy for Glioblastoma?

Glioblastoma multiforme (GBM) represents one of the most frequent malignant brain tumors. Current therapies do not provide real solutions to this pathology. Their failure can be ascribed to a cell subpopulation with stem-like properties called glioma stem cells (GSCs). Therefore, new therapeutic str...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cilibrasi, Chiara, Butta, Valentina, Riva, Gabriele, Bentivegna, Angela
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4897721/ https://www.ncbi.nlm.nih.gov/pubmed/27313600 http://dx.doi.org/10.1155/2016/7175067

Ejemplares similares

Valproic Acid Inhibits Proliferation and Reduces Invasiveness in Glioma Stem Cells Through Wnt/β Catenin Signalling Activation
por: Riva, Gabriele, et al.
Publicado: (2018)

Resveratrol Impairs Glioma Stem Cells Proliferation and Motility by Modulating the Wnt Signaling Pathway
por: Cilibrasi, Chiara, et al.
Publicado: (2017)

A Ploidy Increase Promotes Sensitivity of Glioma Stem Cells to Aurora Kinases Inhibition
por: Cilibrasi, Chiara, et al.
Publicado: (2019)

In vitro anticancer drug test: A new method emerges from the model of glioma stem cells
por: Riva, Gabriele, et al.
Publicado: (2014)

Delineating the Cytogenomic and Epigenomic Landscapes of Glioma Stem Cell Lines
por: Baronchelli, Simona, et al.
Publicado: (2013)

DNA Methylation Changes during In Vitro Propagation of Human Mesenchymal Stem Cells: Implications for Their Genomic Stability?
por: Bentivegna, Angela, et al.
Publicado: (2013)

MV1035 Overcomes Temozolomide Resistance in Patient-Derived Glioblastoma Stem Cell Lines
por: Malacrida, Alessio, et al.
Publicado: (2022)

Stem Cell Based Therapy Option in COVID-19: Is It Really Promising?
por: Irmak, Duygu Koyuncu, et al.
Publicado: (2020)

Tumor Microenvironment and Immune Escape in the Time Course of Glioblastoma
por: Virtuoso, Assunta, et al.
Publicado: (2022)

Promising Prognosis Marker Candidates on the Status of Epithelial–Mesenchymal Transition and Glioma Stem Cells in Glioblastoma
por: Takashima, Yasuo, et al.
Publicado: (2019)

Role of Notch Signaling Pathway in Glioblastoma Pathogenesis
por: Bazzoni, Riccardo, et al.
Publicado: (2019)

Bevacizumab for Glioblastoma—A Promising Drug or Not?
por: Nagane, Motoo, et al.
Publicado: (2013)

The Effect of Culture on Human Bone Marrow Mesenchymal Stem Cells: Focus on DNA Methylation Profiles
por: Bentivegna, Angela, et al.
Publicado: (2016)

Radiomics: The New Promise for Differentiating Progression, Recurrence, Pseudoprogression, and Radionecrosis in Glioma and Glioblastoma Multiforme
por: Alizadeh, Mohammadreza, et al.
Publicado: (2023)

HIF 1 α – a promising target for the treatment of meningiomas
por: Butta, Shristi, et al.
Publicado: (2023)

SWIM tool application to expression data of glioblastoma stem-like cell lines, corresponding primary tumors and conventional glioma cell lines
por: Fiscon, Giulia, et al.
Publicado: (2018)

From cytogenomic to epigenomic profiles: monitoring the biologic behavior of in vitro cultured human bone marrow mesenchymal stem cells
por: Redaelli, Serena, et al.
Publicado: (2012)

The effects of antiepileptic drugs on the growth of glioblastoma cell lines
por: Lee, Ching-Yi, et al.
Publicado: (2016)

Characterization of glioma stem-like cells from human glioblastomas
por: YAMAMURO, SHUN, et al.
Publicado: (2015)

Repurposing phenformin for the targeting of glioma stem cells and the treatment of glioblastoma
por: Jiang, Wei, et al.
Publicado: (2016)

Specific Expression of a New Bruton Tyrosine Kinase Isoform (p65BTK) in the Glioblastoma Gemistocytic Histotype
por: Sala, Luca, et al.
Publicado: (2019)

Pioglitazone Improves In Vitro Viability and Function of Endothelial Progenitor Cells from Individuals with Impaired Glucose Tolerance
por: Spigoni, Valentina, et al.
Publicado: (2012)

Immunohistochemical expression of MGMT in gliomas and its role in ascertaining patient survival
por: Butta, Shristi, et al.
Publicado: (2021)

Pioglitazone: Indian perspective
por: Shukla, Rishi, et al.
Publicado: (2011)

BMP signaling mediates glioma stem cell quiescence and confers treatment resistance in glioblastoma
por: Sachdeva, Rohit, et al.
Publicado: (2019)

Piwil1 Regulates Glioma Stem Cell Maintenance and Glioblastoma Progression
por: Huang, Haidong, et al.
Publicado: (2021)

Initial Combination Therapy With Alogliptin and Pioglitazone in Drug-Naïve Patients With Type 2 Diabetes
por: Rosenstock, Julio, et al.
Publicado: (2010)

Thyrospheres from B-CPAP Cell Line with BRAF and TERT Promoter Mutations have Different Functional and Molecular Features than Parental Cells
por: Caria, Paola, et al.
Publicado: (2017)

Definition of an Inflammatory Biomarker Signature in Plasma-Derived Extracellular Vesicles of Glioblastoma Patients
por: Cilibrasi, Chiara, et al.
Publicado: (2022)

Pioglitazone-Induced Acute Rhabdomyolysis
por: Slim, Raoudha, et al.
Publicado: (2009)

Investigation of the antibacterial activity of pioglitazone
por: Masadeh, Majed M, et al.
Publicado: (2011)

Usage of pioglitazone at Medanta, the Medicity
por: Mithal, Ambrish, et al.
Publicado: (2014)

Pioglitazone: A prudent prescription
por: Kalra, Sanjay, et al.
Publicado: (2013)

Reassessment of Pioglitazone for Alzheimer’s Disease
por: Saunders, Ann M., et al.
Publicado: (2021)

Targeting of glioblastoma cell lines and glioma stem cells by combined PIM kinase and PI3K-p110α inhibition
por: Iqbal, Asneha, et al.
Publicado: (2016)

Genome-Scale Metabolic Modeling of Glioblastoma Reveals Promising Targets for Drug Development
por: Larsson, Ida, et al.
Publicado: (2020)

Juglone in Combination with Temozolomide Shows a Promising Epigenetic Therapeutic Effect on the Glioblastoma Cell Line
por: Barciszewska, Anna-Maria, et al.
Publicado: (2023)

HGG-23. IN VITRO AND IN VIVO PRECLINICAL DRUG SCREENING OF PROMISING THERAPEUTICS FOR DIFFUSE MIDLINE GLIOMA (DMG)
por: Cosentino, Chiara Cianciolo, et al.
Publicado: (2021)

Genomic and Epigenomic Profile of Uterine Smooth Muscle Tumors of Uncertain Malignant Potential (STUMPs) Revealed Similarities and Differences with Leiomyomas and Leiomyosarcomas
por: Conconi, Donatella, et al.
Publicado: (2021)

The Challenges and the Promise of Molecular Targeted Therapy in Malignant Gliomas()
por: Wang, Hongxiang, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_s0251q1du6jbng5h2vfffolv0s